DocDollars

Myovant Sciences Inc.

CA · United States · Reporting entity ID 100000931824

Total reported 2019–2025
$7.07M
#596 of 2,960 reporting companies — 0% of all reported industry payments
$5.04M in general payments across 77,951 records, plus $2.04M in research funding across 604 records.

How it breaks down

General payments $5,038,591
Research funding $2,035,251

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Myovant Sciences Inc. reported $7.07M to US doctors and teaching hospitals from 2019 to 2025, ranking #596 of 2,960 reporting companies. 29% of that was research funding and 71% general payments such as consulting, speaking, food and travel. 77,951 general payment records and 604 research records were filed.

Common questions about Myovant Sciences Inc.

How much has Myovant Sciences Inc. paid US doctors?

Myovant Sciences Inc. reported $7,073,843 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $5,038,591 in general payments, $2,035,251 in research funding.

How does Myovant Sciences Inc. rank among drug and device companies?

It ranks #596 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Myovant Sciences Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.